Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway

被引:0
作者
P Pandey
P Seshacharyulu
S Das
S Rachagani
M P Ponnusamy
Y Yan
S L Johansson
K Datta
M Fong Lin
S K Batra
机构
[1] University of Nebraska Medical Center,Department of Biochemistry and Molecular Biology
[2] Eppley Institute for Research in Cancer and Allied Diseases,Department of Pathology and Microbiology
[3] University of Nebraska Medical Center,undefined
[4] College of Medicine,undefined
[5] University of Nebraska Medical Center,undefined
来源
British Journal of Cancer | 2013年 / 108卷
关键词
protein phosphatase type 2A; phosphorylation; dephosphorylation; AKT signalling; prostate cancer; PP2A subunits;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2590 / 2600
页数:10
相关论文
共 350 条
  • [1] Baharians Z(1998)Autoregulation of protein phosphatase type 2A expression J Biol Chem 273 19019-19024
  • [2] Schonthal AH(2011)Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implications Mol Cancer Ther 10 720-731
  • [3] Bhardwaj A(2011)Protein kinases and phosphatases in the control of cell fate Enzyme Res 2011 329098-303
  • [4] Singh S(2001)Lessons to be learned from the androgen receptor Eur J Dermatol 11 301-1195
  • [5] Srivastava SK(2000)Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine–threonine phosphatase 2A in human neoplasms Oncogene 19 1191-8192
  • [6] Honkanen RE(2005)Cancer-associated PP2A Aalpha subunits induce functional haploinsufficiency and tumorigenicity Cancer Res 65 8183-136
  • [7] Reed E(2004)Identification of specific PP2A complexes involved in human cell transformation Cancer Cell 5 127-57
  • [8] Singh AP(2007)Structural basis of PP2A inhibition by small t antigen PLoS Biol 5 e202-5010
  • [9] Bononi A(2007)Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme Nature 445 53-190
  • [10] Agnoletto C(2011)Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer J Biomed Sci 18 63-6308